Company intelligence / Profile preview

Houston Cyclotron Partners

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

Houston Cyclotron Partners operated a cyclotron-based radiopharmacy business (Cyclotope Radiopharmacy) in Houston, supplying radiopharmaceuticals/APIs; this radiopharmacy operation was acquired by SOFIE, expanding SOFIE’s U.S. radiopharmacy network to 17 sites serving more than 400,000 patients annually at roughly 700 clinics.[1][5][9] No specific drug development pipeline or clinical trial portfolio is publicly described.

Modalities: RadiopharmaceuticalRadiopharmaceutical (diagnostic)Radiopharmaceutical (therapeutic)
Industry: Contract Manufacturing Organization

Partnerships

SOFIE (acquirer of Cyclotope Radiopharmacy from Houston Cyclotron Partners)[1][5][9]

Beyond the preview

Go deeper on Houston Cyclotron Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Houston Cyclotron Partners.

Explore the full profile